We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ENSC market cap is 1.64M. The company's latest EPS is USD -3.3775 and P/E is -3.97.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 790k | 490k | 435k | 516k | 306k |
| Operating Income | -2.56M | -2.29M | -2.71M | -3.15M | -1.84M |
| Net Income | -2.2M | -2.24M | -2.69M | -3.5M | -3.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 3.53M | 2.52M | 2.23M |
| Operating Income | -3.33M | -1.37M | -19.87M | -24.22M | -10.72M |
| Net Income | 366k | 2.41M | -29.89M | -25.09M | -10.63M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.92M | 6.36M | 3.22M | 2.71M | 5.07M |
| Total Liabilities | 4.07M | 2.57M | 2.06M | 3.36M | 1.65M |
| Total Equity | -152k | 3.79M | 1.16M | -651k | 3.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 196.51M | 12.86M | 16.42M | 5.89M | 2.71M |
| Total Liabilities | 10.34M | 7.8M | 24.58M | 9.92M | 3.36M |
| Total Equity | 5M | 5M | -8.16M | -4.03M | -651k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.61M | -6.72M | -8.98M | -10.78M | -3.41M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.88M | 7.4M | 7.3M | 8.76M | 5.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.43M | -864k | -8.24M | -17.89M | -10.78M |
| Investing | 11.85M | 183.4M | N/A | 4k | N/A |
| Financing | -11.03M | -183.55M | 20.31M | 8.77M | 8.76M |
| Market Cap | 1.64M |
| Price to Earnings Ratio | -3.97 |
| Price to Sales Ratio | 18.91 |
| Price to Cash Ratio | 37.53 |
| Price to Book Ratio | -64.81 |
| Dividend Yield | - |
| Shares Outstanding | 3.15M |
| Average Volume (1 week) | 82.32k |
| Average Volume (1 Month) | 152.67k |
| 52 Week Change | -78.06% |
| 52 Week High | 2.64 |
| 52 Week Low | 0.48 |
| Spread (Intraday) | 1.3 (76.45%) |
| Company Name | Ensysce Biosciences Inc |
| Address |
250 west 57th street new york, new york 10107 |
| Website | https://www.leisureacq.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
